Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Trends in opioid use in commercially insured and Medicare Advantage populations in 2007–16: retrospective cohort study.

Jeffery MM, Hooten M, Henk HJ, et al. Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study. BMJ. 2018;362:k2833. doi:10.1136/bmj.k2833.

Save
Print
August 29, 2018
Jeffery MM, Hooten M, Henk HJ, et al. BMJ. 2018;362:k2833.
View more articles from the same authors.

This retrospective study of claims data found that use of opioid medication among commercially ensured and Medicare populations did not change substantially between 2007 and 2017, despite increasing concerns about risks of opioid use. Opioid prescribing rates were higher and doses were larger among disabled Medicare beneficiaries.

Save
Print
Cite
Citation

Jeffery MM, Hooten M, Henk HJ, et al. Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study. BMJ. 2018;362:k2833. doi:10.1136/bmj.k2833.